Literature DB >> 14602918

p53 stimulates human topoisomerase I activity by modulating its DNA binding.

Kent Søe1, Frank Grosse.   

Abstract

The tumor suppressor protein p53 and the human DNA topoisomerase I (htopoI) interact with each other, which leads to a stimulation of the catalytic activity of htopoI. Moreover, p53 stimulates the topoisomerase I-induced recombination repair (TIRR) reaction. However, little was known about how p53 stimulates this topoisomerase I activity. Here we demonstrate that monomeric p53 is sufficient for the stimulation of the topoisomerase I-catalyzed relaxation activity, but the tetrameric form of p53 is required for the stimulation of TIRR. We also show that p53 stimulates topoisomerase I activity by increasing the dissociation of htopoI from DNA. Since htopoI forms a closed ring structure around the DNA, our results suggest that p53 induces a conformational change within htopoI that results in an opening of the clamp, and thereby releases htopoI from DNA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14602918      PMCID: PMC275542          DOI: 10.1093/nar/gkg846

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  24 in total

1.  The interaction between p53 and DNA topoisomerase I is regulated differently in cells with wild-type and mutant p53.

Authors:  C Gobert; A Skladanowski; A K Larsen
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

2.  Topoisomerase I-mediated cytotoxicity of N-methyl-N'-nitro-N-nitrosoguanidine: trapping of topoisomerase I by the O6-methylguanine.

Authors:  P Pourquier; J L Waltman; Y Urasaki; N A Loktionova; A E Pegg; J L Nitiss; Y Pommier
Journal:  Cancer Res       Date:  2001-01-01       Impact factor: 12.701

3.  p53 dependence of topoisomerase I recruitment in vivo.

Authors:  Y Mao; S Okada; L S Chang; M T Muller
Journal:  Cancer Res       Date:  2000-08-15       Impact factor: 12.701

4.  Eukaryotic topoisomerase I-DNA interaction is stabilized by helix curvature.

Authors:  S Krogh; U H Mortensen; O Westergaard; B J Bonven
Journal:  Nucleic Acids Res       Date:  1991-03-25       Impact factor: 16.971

5.  Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA.

Authors:  M R Redinbo; L Stewart; P Kuhn; J J Champoux; W G Hol
Journal:  Science       Date:  1998-03-06       Impact factor: 47.728

6.  Ultraviolet-induced DNA damage stimulates topoisomerase I-DNA complex formation in vivo: possible relationship with DNA repair.

Authors:  D Subramanian; B S Rosenstein; M T Muller
Journal:  Cancer Res       Date:  1998-03-01       Impact factor: 12.701

7.  Wild-type and mutant forms of p53 activate human topoisomerase I: a possible mechanism for gain of function in mutants.

Authors:  A Albor; S Kaku; M Kulesz-Martin
Journal:  Cancer Res       Date:  1998-05-15       Impact factor: 12.701

8.  Induction of topoisomerase I cleavage complexes by 1-beta -D-arabinofuranosylcytosine (ara-C) in vitro and in ara-C-treated cells.

Authors:  P Pourquier; Y Takebayashi; Y Urasaki; C Gioffre; G Kohlhagen; Y Pommier
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

9.  SUMO-1 conjugation to topoisomerase I: A possible repair response to topoisomerase-mediated DNA damage.

Authors:  Y Mao; M Sun; S D Desai; L F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

10.  Casein kinase II stimulates Xenopus laevis DNA topoisomerase I by physical association.

Authors:  G J Kordiyak; S Jakes; T S Ingebritsen; R M Benbow
Journal:  Biochemistry       Date:  1994-11-15       Impact factor: 3.162

View more
  6 in total

1.  WRN protects against topo I but not topo II inhibitors by preventing DNA break formation.

Authors:  Markus Christmann; Maja T Tomicic; Christopher Gestrich; Wynand P Roos; Vilhelm A Bohr; Bernd Kaina
Journal:  DNA Repair (Amst)       Date:  2008-10-15

2.  Comparative analysis of topoisomerase IB inhibition and DNA intercalation by flavonoids and similar compounds: structural determinates of activity.

Authors:  Michael R Webb; Susan E Ebeler
Journal:  Biochem J       Date:  2004-12-15       Impact factor: 3.857

3.  Preferential binding of hot spot mutant p53 proteins to supercoiled DNA in vitro and in cells.

Authors:  Marie Brázdová; Lucie Navrátilová; Vlastimil Tichý; Kateřina Němcová; Matej Lexa; Roman Hrstka; Petr Pečinka; Matej Adámik; Borivoj Vojtesek; Emil Paleček; Wolfgang Deppert; Miroslav Fojta
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

4.  CK2-mediated hyperphosphorylation of topoisomerase I targets serine 506, enhances topoisomerase I-DNA binding, and increases cellular camptothecin sensitivity.

Authors:  Keya Bandyopadhyay; Pingchuan Li; Ruth A Gjerset
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

5.  Poly(ADP-RIBOSE) polymerase-1 (Parp-1) antagonizes topoisomerase I-dependent recombination stimulation by P53.

Authors:  Cindy Baumann; Gisa S Boehden; Alexander Bürkle; Lisa Wiesmüller
Journal:  Nucleic Acids Res       Date:  2006-02-09       Impact factor: 16.971

6.  A systematic review and meta-analysis of topoisomerase inhibition in pre-clinical glioma models.

Authors:  Toni Rose Jue; Emily S Sena; Malcolm R Macleod; Kerrie L McDonald; Theodore C Hirst
Journal:  Oncotarget       Date:  2018-01-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.